소아 천식 조절 지표로서의 기관지확장제반응의 유용성
Usefulness of bronchodilator response as an index of asthma control in children
4
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Assessing asthma control is important for proper management, and various indices for objective assessment of asthma control, such as fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) score have been proposed. Recently, bronchodilator response (BDR) was reported as a marker of poor asthma control in adults. This study aimed to assess the usefulness of BDR as a biomarker for childhood asthma. Methods: A total of 305 children diagnosed with asthma were included. Spirometry with bronchodilator test was done at the time of diagnosis and about 14 months after asthma treatment. All children were evaluated by childhood asthma control test (c-ACT) and FeNO after asthma treatment. The patients were divided into 2 groups according to BDR results: the positive and negative BDR groups. Various biomarkers for asthma control, such as c-ACT, FeNO and changes of forced expiratory volume in 1 second (FEV1), were compared between the 2 groups. Results: Of the 305 patients, 143 (46.9%) were positive and 162 (53.1%) were negative for BDR. The BDR-positive group showed lower FEV1. In the BDR positive group, FEV1 was significantly increased after asthma treatment, especially in children with airflow limitation which was defined as below 80% of FEV1 or atopy. In atopic children, BDR showed a significant negative correlation with c-ACT and a positive correlation with FeNO. Conclusion: In asthmatic children with airflow limitation at the time of diagnosis, BDR can be a useful index for predicting improvement in lung function by asthma maintenance treatment. BDR could be a reliable marker for the assessment of asthma control in atopic children.
Abstract
Purpose: Assessing asthma control is important for proper management, and various indices for objective assessment of asthma control, such as fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) score have been proposed. Recently, bronchodilator response (BDR) was reported as a marker of poor asthma control in adults. This study aimed to assess the usefulness of BDR as a biomarker for childhood asthma. Methods: A total of 305 children diagnosed with asthma were included. Spirometry with bronchodilator test was done at the time of diagnosis and about 14 months after asthma treatment. All children were evaluated by childhood asthma control test (c-ACT) and FeNO after asthma treatment. The patients were divided into 2 groups according to BDR results: the positive and negative BDR groups. Various biomarkers for asthma control, such as c-ACT, FeNO and changes of forced expiratory volume in 1 second (FEV1), were compared between the 2 groups. Results: Of the 305 patients, 143 (46.9%) were positive and 162 (53.1%) were negative for BDR. The BDR-positive group showed lower FEV1. In the BDR positive group, FEV1 was significantly increased after asthma treatment, especially in children with airflow limitation which was defined as below 80% of FEV1 or atopy. In atopic children, BDR showed a significant negative correlation with c-ACT and a positive correlation with FeNO. Conclusion: In asthmatic children with airflow limitation at the time of diagnosis, BDR can be a useful index for predicting improvement in lung function by asthma maintenance treatment. BDR could be a reliable marker for the assessment of asthma control in atopic children.
참고문헌 (26)
- Asher MI, "International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods", Eur Respir J, 8, pp.483~491 (1995)
- Hong SJ, "Self-reported prevalence and risk factors of asthma among Korean adolescents: 5-year follow-up study, 1995-2000", Clin Exp Allergy, 34, pp.1556~1562 (2004)
- 설인숙, "Prescription Patterns and Burden of Pediatric Asthma in Korea", Allergy, Asthma & Immunology Research, 11(2), pp.280~290 (2019), 대한천식알레르기학회
- Liu AH, "Development and cross-sectional validation of the Childhood Asthma Control Test", J Allergy Clin Immunol, 119, pp.817~825 (2007)
- Juniper EF, "Asthma Control Questionnaire in children: validation, measurement properties, interpretation", Eur Respir J, 36, pp.1410~1416 (2010)
- Chipps B, "Longitudinal validation of the Test for Respiratory and Asthma Control in Kids in pediatric practices", Pediatrics, 127, pp.e737~e747 (2011)
- Lu M, "FeNO and asthma treatment in children: a systematic review and meta-analysis", Medicine (Baltimore), 94, pp.e347~ (2015)
- Petsky HL, "Exhaled nitric oxide levels to guide treatment for children with asthma", Cochrane Database Syst Rev, 11, pp.CD011439~ (2016)
- American Thoracic Society, "ATS", ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005, 2005, pp.171, 912~930
- Melosini L, "Asthma control test (ACT): comparison with clinical, functional, and biological markers of asthma control", J Asthma, 49, pp.317~323 (2012)
- Heffler E, "Bronchodilator response as a marker of poor asthma control", Respir Med, 112, pp.45~50 (2016)
- Galant SP, "The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometry", J Pediatr, 158, pp.953~959.e1 (2011)
- Kim YH, "Usefulness of impulse oscillometry and fractional exhaled nitric oxide in children with Eosinophilic bronchitis", Pediatr Pulmonol, 48, pp.221~228 (2013)
- Miller MR, "Standardisation of spirometry", Eur Respir J, 26, pp.319~338 (2005)
- Ferrer Galván M, "Is the bronchodilator test an useful tool to measure asthma control", Respir Med, 126, pp.26~31 (2017)
- "2018 Update GINA report, global strategy for asthma management and prevention" (2018)[URL]
- Schatz M, "Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists", J Allergy Clin Immunol, 117, pp.549~556 (2006)
- Ulrik CS, "Mortality and markers of risk of asthma death among 1,075 outpatients with asthma", Chest, 108, pp.10~15 (1995)
- Pongracic JA, "Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents", J Allergy Clin Immunol, 138, pp.1030~1041 (2016)
- Kim YH, "Association of extended nitric oxide parameters with bronchial hyperresponsiveness and bronchodilator response in children with asthma", J Breath Res, 11, pp.046003~ (2017)
- Parker AL, "Airway reactivity is a determinant of bronchodilator responsiveness after methacholine-induced bronchoconstriction", J Asthma, 41, pp.671~677 (2004)
- Goleva E, "Airway remodeling and lack of bronchodilator response in steroid-resistant asthma", J Allergy Clin Immunol, 120, pp.1065~1072 (2007)
- Tantisira KG, "Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma", J Allergy Clin Immunol, 117, pp.1264~1271 (2006)
- Siegfried Bauer, "Assessment of Bronchodilator Responsiveness Following Methacholine-Induced Bronchoconstriction in Children With Asthma", Allergy, Asthma & Immunology Research, 3(4), pp.245~250 (2011), 대한천식알레르기학회
- Mogensen I, "Fixed airflow obstruction relates to eosinophil activation in asthmatics", Clin Exp Allergy, 49, pp.155~162 (2019)
- Reddel HK, "An official American Thoracic Society", European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice, 2009, pp.180, 59~99